Prelude Capital Management’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,694
| Closed | -$251K | – | 1936 |
|
|
2019
Q3 | $251K | Buy |
+3,694
| New | +$251K | 0.01% | 402 |
|
|
2019
Q2 | – | Sell |
-315
| Closed | -$22K | – | 1917 |
|
|
2019
Q1 | $22K | Sell |
315
-28
| -8% | -$1.96K | ﹤0.01% | 939 |
|
|
2018
Q4 | $22K | Buy |
343
+23
| +7% | +$1.48K | ﹤0.01% | 913 |
|
|
2018
Q3 | $22K | Buy |
320
+120
| +60% | +$8.25K | ﹤0.01% | 955 |
|
|
2018
Q2 | $10K | Hold |
200
| – | – | ﹤0.01% | 1206 |
|
|
2018
Q1 | $6K | Buy |
+200
| New | +$6K | ﹤0.01% | 1255 |
|
|
2017
Q4 | – | Sell |
-1,200
| Closed | -$39K | – | 1740 |
|
|
2017
Q3 | $39K | Buy |
+1,200
| New | +$39K | ﹤0.01% | 1062 |
|
|
2017
Q1 | – | Sell |
-5,300
| Closed | -$156K | – | 1856 |
|
|
2016
Q4 | $156K | Buy |
5,300
+3,794
| +252% | +$112K | 0.02% | 635 |
|
|
2016
Q3 | $44K | Sell |
1,506
-1,900
| -56% | -$55.5K | ﹤0.01% | 1021 |
|
|
2016
Q2 | $88K | Buy |
3,406
+1,106
| +48% | +$28.6K | 0.01% | 768 |
|
|
2016
Q1 | $57K | Buy |
+2,300
| New | +$57K | 0.01% | 871 |
|
|
2015
Q1 | – | Sell |
-2,200
| Closed | -$70K | – | 2193 |
|
|
2014
Q4 | $70K | Sell |
2,200
-300
| -12% | -$9.55K | 0.01% | 1066 |
|
|
2014
Q3 | $71K | Buy |
2,500
+300
| +14% | +$8.52K | 0.01% | 1158 |
|
|
2014
Q2 | $60K | Hold |
2,200
| – | – | 0.01% | 1161 |
|
|
2014
Q1 | $58K | Buy |
+2,200
| New | +$58K | 0.01% | 1098 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 1910 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 1729 |
|